LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 0.99 USD -9.17% Market Closed
Market Cap: 26m USD
Have any thoughts about
LAVA Therapeutics NV?
Write Note

P/FCFE
Price to FCFE

-0.9
Current
-2
Median
23.4
Industry
Higher than median
Lower than industry value

Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

P/FCFE
-0.9
=
Market Cap
26m USD
/
FCFE
-28.9m USD
All Countries
Close
 
NL
LAVA Therapeutics NV
NASDAQ:LVTX
Average P/FCFE: 29.6
Negative Multiple: -0.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -3 222 687.7
US
Abbvie Inc
NYSE:ABBV
12.4
US
Amgen Inc
NASDAQ:AMGN
23.8
US
Gilead Sciences Inc
NASDAQ:GILD
11.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -78.2
US
E
Epizyme Inc
F:EPE
Negative Multiple: -425.8
AU
CSL Ltd
ASX:CSL
76.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
23.6
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.5
NL
argenx SE
XBRU:ARGX
Negative Multiple: -113.6

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A

See Also

Discover More